Page last updated: 2024-10-24

busulfan and Epidermolysis Bullosa Dystrophica

busulfan has been researched along with Epidermolysis Bullosa Dystrophica in 1 studies

Epidermolysis Bullosa Dystrophica: Form of epidermolysis bullosa characterized by atrophy of blistered areas, severe scarring, and nail changes. It is most often present at birth or in early infancy and occurs in both autosomal dominant and recessive forms. All forms of dystrophic epidermolysis bullosa result from mutations in COLLAGEN TYPE VII, a major component fibrils of BASEMENT MEMBRANE and EPIDERMIS.

Research Excerpts

ExcerptRelevanceReference
"Recessive dystrophic epidermolysis bullosa is a severe, incurable, inherited blistering disease caused by COL7A1 mutations."1.42Reduced Toxicity Conditioning and Allogeneic Hematopoietic Progenitor Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa. ( Baxter-Lowe, L; Bruckner, A; Cairo, MS; Chen, M; Christiano, AM; Fabricatore, S; Geyer, MB; Giller, R; Harel, S; Kandel, J; Kiuru, M; LeBoeuf, N; McGrath, J; Morel, KD; Radhakrishnan, K; Uitto, J; Umegaki, N; Woodley, D, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Geyer, MB1
Radhakrishnan, K1
Giller, R1
Umegaki, N1
Harel, S1
Kiuru, M1
Morel, KD1
LeBoeuf, N1
Kandel, J1
Bruckner, A1
Fabricatore, S1
Chen, M1
Woodley, D1
McGrath, J1
Baxter-Lowe, L1
Uitto, J1
Christiano, AM1
Cairo, MS1

Other Studies

1 other study available for busulfan and Epidermolysis Bullosa Dystrophica

ArticleYear
Reduced Toxicity Conditioning and Allogeneic Hematopoietic Progenitor Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa.
    The Journal of pediatrics, 2015, Volume: 167, Issue:3

    Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Busulfan; Child; Collagen Type VII; Epidermolysis Bu

2015